INTRODUCTION
Uterine vascular malformation (UVM) is a tangle of abnormal arteriovenous connections located in or around the uterus (1) . UVM can be congenital or acquired, and in 1−2% of cases, massive vaginal bleeding or intraperitoneal hemorrhage can occur, which can be life-threatening (2, 3) . These complications may tion or hysterectomy. Currently, arterial embolization is the preferred treatment because it is minimally invasive and has the potential to preserve fertility.
The purpose of our study is to describe our experience in using transarterial bilateral uterine arteries (UAE) in patients with acquired UVM, and to evaluate the long term clinical outcomes. 
MATERIALS AND METHODS

RESULTS
Angiographic success was achieved in all 19 patients. One patient required repeat embolization since the UVM was not completely embolized due to prominent high flow in the first session.
Therefore, a total of 20 procedures were performed in 19 patients.
Angiography revealed the presence of a pseudoaneurysm during five procedures (25%) ( Fig. 1 Currently, the diagnostic modalities available for UVM are ultrasonography (US) and MRI. Color and duplex Doppler US are especially good screening and diagnostic methods (6, 9, 13) . The most common Gray-Scale ultrasonographic feature of UVM is the anechoic tubular space in the myometrium without a mass effect, but this feature is nonspecific; hence, the diagnosis of AVM is not based on Gray-Scale ultrasonographic morphology.
On color Doppler US, a tangle of tortuous vessels with multidi- In the past, hysterectomy or surgical ligation of the uterine artery was widely performed for the treatment of UVM (16) . However, hysterectomy has a major limitation as it cannot preserve the patient' s fertility after surgery (17) (18) (19) .
Wu et al. (17) introduced laparoscopic bipolar coagulation of uterine vessels, which can relieve symptoms and has advantages such as shorter surgical times and absence of radiation exposure.
However, general anesthesia and laparoscopic surgery are required.
Transarterial embolization of a UVM was first introduced by Forssman et al. (18) . The benefits of UAE are that it is minimally invasive, preserves the uterus, requires less hospitalization and results in a shorter recovery period. Currently, hysterectomy is performed to treat uterine AVM only in those women who do not want additional pregnancies or who do not have the capacity to bear children. In addition, many previous studies have revealed that UAE is safer and less invasive than surgical procedures (19) (20) (21) .
UAE should be performed in bilateral uterine arteries, because the uterine artery has many collateral supply channels and reperfusion from a contralateral uterine artery can occur, which may induce continuous bleeding or rebleeding after embolization (22) (23) (24) . Embolization materials widely used in these procedures are gelatin sponge particles, polyvinyl alcohol (PVA), coils, glues, detachable balloons, or a combination thereof (15, 19, (21) (22) (23) . Gelatin sponge particles are used as a means of causing mechanical obstruction, slowing blood flow and hastening thrombus formation (25) . However, embolization using gelatin sponge particles causes temporary vessel occlusion and allows recanalization in a few weeks, leading to a risk of reperfusion or rebleeding (25) . delivery was 20.1 months in our study. Therefore, our study confirms the previously reported result regarding the potential to become pregnant after particulate UAE (3, 29, 30) .
The possible complications associated with UAE are groin hematoma, uterine ischemia, pelvic infections such as tubo-ovarian abscesses, endometritis, and transient or permanent amenorrhea (31) . In our study, the number of minor adverse events due to the procedure was low. Pelvic pain was observed during the first week in three patients, but the pain was relieved by conservative treatment. None of the patients presented with amenorrhea, as described in 4% of the cases after bilateral UAE for the treatment of uterine myomas. No major adverse events were observed in our study.
Our study has some limitations. The retrospective design and the small number of patients included in the study do not allow extensive statistical analysis.
In conclusion, transarterial bilateral UAE is a safe and effective treatment in patients with vaginal bleeding caused by acquired UVM. This procedure allows preservation of uterine function with the possibility of future pregnancy. Transarterial bilateral UAE should be considered as a primary treatment option in these patients.
